Venoarterial extracorporeal life support (VA-ECLS) is used in ICUs (intensive care units) for the most extreme presentations of acute and severe cardiogenic shock, and one of the main issues the clinicians have to deal with is the weaning from VA-ECLS. In this study, a patient-specific model of the cardiovascular system connected to a VA-ECLS is built to improve the understanding of this complex system. Pig experiments are performed to validate the model, and the results are quite promising since the mean difference between experimental data and simulation is smaller than 5% for all the hemodynamic quantities. It is also a major objective of this paper to provide a proof-of-concept analysis that model-based approaches could improve the weaning strategy for VA-ECLS therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165357 | PMC |
| http://dx.doi.org/10.1155/2020/4503919 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bridge to simultaneous heart-kidney transplantation via extracorporeal life support: National outcomes in the new heart allocation policy era.
J Heart Lung Transplant
January 2025
Division of Cardiac Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, New York. Electronic address:
Article Synopsis
- This study analyzed the outcomes of 774 adult patients who received simultaneous heart-kidney transplants (SHK) under the revised UNOS heart allocation policy, focusing on 50 patients who were supported by veno-arterial extracorporeal life support (VA-ECLS) compared to 724 without.
- Results showed that VA-ECLS patients were younger and had better kidney function before transplant but faced higher rates of temporary dialysis and lower survival rates after the procedure, with significant differences in early mortality and cardiac allograft failure.
- The findings indicate that while VA-ECLS patients have similar renal outcomes post-transplant, they experience greater risks for early mortality and complications related to heart trans
Extracorporeal Life Support Use in Mixed Distributive-Obstructive Shock Following an Electrical Injury: A Case Report.
J Burn Care Res
August 2024
Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA.
Article Synopsis
- Electrical burn injuries can lead to severe consequences, including major amputations and life-threatening conditions like sepsis and pulmonary embolism.
- A case is presented where a patient needed extensive surgical interventions and advanced life support (VA ECLS) after suffering from an electrical shock.
- This case highlights the potential effectiveness of VA ECLS as a supportive treatment for patients with complex complications from electrical burns, particularly when standard treatments fail.
Venoarterial Extracorporeal Life Support Use in Acute Pulmonary Embolism Shows Favorable Outcomes.
Ann Thorac Surg
July 2024
Division of Cardiac Surgery, Department of Surgery, University of Virginia, Charlottesville, Virginia. Electronic address:
Background: Differences in outcomes by indication for venoarterial extracorporeal life support (VA-ECLS) are poorly described. We hypothesized that patients on VA-ECLS for acute pulmonary embolism (PE) have fewer complications and better survival than patients on VA-ECLS for other indications.
Methods: All patients ≥18 years on VA-ECLS from the Extracorporeal Life Support Organization global registry (2010-2019) were evaluated (n = 29,842).
Mechanical circulatory support with ECMELLA approach in severe cardiogenic shock patients-state of the art.
J Thorac Dis
September 2023
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany.
Long-term outcomes of patients bridged to recovery with venoarterial extracorporeal life support.
Perfusion
November 2024
Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA.
Article Synopsis
- - This study investigated the long-term outcomes of 166 patients who recovered from cardiogenic shock using venoarterial extracorporeal life support (VA-ECLS) and were discharged without heart replacement therapy (HRT).
- - Follow-up data showed a 1-year survival rate of 85.6% and a 5-year survival rate of 60.6%, with a significant predictor of increased mortality being a history of congestive heart failure.
- - The findings suggest that patients discharged without HRT should have regular outpatient follow-ups due to the heightened risk of recurrent heart failure and mortality.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!